✦ LIBER ✦

9135 Erlotinib as maintenance therapy after platinun-based chemotherapy in advanced non-small-cell lung cancer (NSCLC): a phase II trial

✍ Scribed by Cobo-Dols, M.; Barneto-Aranda, I.; Bernabé-Caro, R.; Valdivia, J.; Fernandez-Canton, I.; Cruzdela, L.; Rueda-Ramos, A.; Villatoro, R.; Beló, J.

Book ID: 122387547
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 45 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71848-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5 Brachytherapy plus chemotherapy in adv

5 Brachytherapy plus chemotherapy in advanced non small cell lung cancer (NSCLC) phase II trial

✍ Grigorescu, A.; Bacinschi, X.; Radoi, S.; Ciocaltei, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB

A phase II trial of erlotinib as mainten

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

✍ Casal Rubio, J.; Fírvida-Pérez, J. L.; Lázaro-Quintela, M.; Barón-Duarte, F. J.; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 439 KB

Phase II trial of thalidomide as mainten

Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy

✍ Dowlati, Afshin; Subbiah, Shanmuga; Cooney, Matthew; Rutherford, Kimberly; Mekha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Curative radiation therapy after VIP, a

Curative radiation therapy after VIP, a cisplatin-based chemotherapy, in stage IIIB non-small cell lung cancer (NSCLC): A phase II study

✍ Silvano, G; Baldini, E; Campoccia, S; Tibaldi, C; Cionini, L 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

O-106 A phase II trial of cetuximab as t

O-106 A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)

✍ Hanna, N.; Bonomi, P.; Lynch, T.; Ansari, R.; Govindan, R.; Janne, P.; Lilenbaum 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB